On Tuesday, Shares of Avago Technologies Limited (NASDAQ:AVGO), loss -3.61% to $116.79.
Avago Technologies, declared that it has accomplished the tender offer by Avago, its indirect wholly-owned partner, Avago Technologies Wireless (U.S.A.) Manufacturing Inc. (“Parent”), and Parent’s wholly-owned partner, Emerald Merger Sub, Inc., to acquire outstanding shares of common stock of Emulex Corporation (“Emulex”) (ELX), a leader in network connectivity, monitoring and administration. Avago anticipates to complete the acquisition of Emulex recently through a merger under Delaware law following the merger agreement among the parties. Upon the completion of the merger, Emulex will become a wholly-owned partner of Avago, and Emulex’s shares will cease to be traded on the New York Stock Exchange.
Avago Technologies Limited designs, develops, and supplies semiconductor devices with a focus on analog III-V based products. The company operates through four segments: Wireless Communications, Wired Infrastructure, Enterprise Storage, and Industrial & Other segments. Its product portfolio comprises RF power amplifiers, RF filters, RF front end modules, ambient light sensors, proximity sensors, low noise amplifiers, multimarket-wave mixers, diodes, fiber optic transceivers, serializer/deserializer ASICs, and optical laser and receiver components.
Shares of Domtar Corporation (NYSE:UFS), declined -3.59% to $42.66, during its last trading session.
Domtar Corporation, declared that its Board of Directors has approved its first quarterly dividend for the 2015 fiscal year on its common stock (UFS) (UFS). The dividend of US$0.40 per share is payable on July 15, 2015 to stockholders of record on July 2 , 2015.
Domtar Corporation designs, manufactures, markets, and distributes communications papers, specialty and packaging papers, and absorbent hygiene products in the United States, Canada, Europe, Asia, and internationally. It operates in two segments, Pulp and Paper, and Personal Care.
At the end of Tuesday’s trade, Shares of VASCO Data Security International Inc. (NASDAQ:VDSI), dipped -3.56% to $25.17.
VASCO Data Security International, declared that Caesars Entertainment Corporation (CZR), the world’s most diversified casino-entertainment provider, has implemented VASCO’s DIGIPASS for Mobile software-based strong authentication solution.
The recently-released 2015 Verizon Data Breach Investigations Report identified that 95% of Web App attacks make use of stolen credentials, such as a stolen user name and password. By implementing stronger authentication methods, companies can significantly reduce the chances that hackers will succeed at a data breach.
DIGIPASS for Mobile is a software-based two-factor authentication solution that delivers strong protection against threats and data loss in addition to frictionless authentication for users. With DIGIPASS for Mobile, a user’s mobile phone serves as their secure authentication device. DIGIPASS for Mobile supports innovative authentication options counting QR Code Scanning and Transparent OTP, and enables multi-device support so that a user can use any pre-registered device for authentication.
VASCO Data Security International, Inc., together with its auxiliaries, designs, develops, markets, and supports hardware and software security systems that manage and secure access to information assets worldwide.
Finally, Amarin Corporation plc (NASDAQ:AMRN), ended its last trade with -3.55% loss, and closed at $1.90.
Amarin Corporation, declared that it will host a conference call with members of Amarin senior administration to talk about the company’s first quarter 2015 financial results and provide an operational update on Friday, May 8, at 8:00 a.m. ET. The conference call will follow the anticipated release of the company’s financial results earlier that day.
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product comprises Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
